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INTRODUCTION
Phthalates, a family of phthalic acid esters are widely used 
as plasticizers in the manufacture of polymer-products offering 
flexibility, durability and elasticity to coating materials, cable, 
film, tubes, wire, flooring materials, cleanser, automobile, 
soap, shampoo, hair-sprayer, color-cosmetics and even per-
sonal care products (Takatori et al., 2004; Calafat and McKee, 
2006). Phthalates such as di-2-ethylhexylphthalate (DEHP), 
diisodecylphthalate (DIDP), and diisononylphthalate (DINP) 
have been used worldwide and their global production has 
reached nearly 10 million tons per year. Unfortunately, phthal-
ates are associated with undesirable human health effects 
that include abnormal reproductive organ developments (Liu 
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Phthalates widely used in the manufacture of plastics have deeply penetrated into our everyday lives. Recently, a concern over the 
toxicity of phthalates on thyroid, has been raised but in most of cases, the doses employed were unrealistically high. To investigate 
the effects of phthalates on thyroid, we investigated the effects of the repeated oral exposure to low to high doses (0.3, 3, 30 and 
150 mg/kg) di-2-ethylhexylphthalate (DEHP) from weaning to maturity for 90 days in juvenile rats on the thyroid. The histological 
examination revealed that DEHP significantly induced hyperplasia in the thyroid from the doses of 30 mg/kg, which was confirmed 
with Ki67 staining. In line with this finding, increased mRNA expression of thyrotropin releasing hormone (Trh) was observed in the 
thyroid of female at 0.3 mg/kg and 150 mg/kg as determined by RNAseq analysis. Moreover, significantly increased expression 
of parathyroid hormone (Pth) in the female at 0.3 mg/kg, and thyroglobulin (Tg) and thyroid hormone responsive (Thrsp) in the 
male at 0.3 mg/kg were noted in the blood, of which changes were substantially attenuated at 150 m/kg, alluding the meaningful 
effects of low dose DEHP on the thyroid hormone regulation. Urinary excretion of mono-2-ethylhexyl-phthalate (MEHP), a major 
metabolite of DEHP was determined to be 4.10 and 12.26 ppb in male, 6.65 and 324 ppb in female at 0.3 and 30 mg/kg DEHP, 
respectively, which fell within reported human urine levels. Collectively, these results suggest a potential adverse effects of low 
dose phthalates on the thyroid.
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et al., 2018), tumorigenesis (Takeshita et al., 2006; Miao et 
al., 2017), and reproductive toxicity with respect to spermato-
genesis and fetal development (Latini et al., 2003; Martino-
Andrade and Chahoud, 2010), and respiratory toxicity (Lopez-
Carrillo et al., 2010; Ventrice et al., 2013).
Especially concern over the toxicity of DEHP is increasing 
due to the heavy use of polyvinylchloride (PVC) for food pack-
aging materials and resultant ubiquitous presence of DEHP in 
community and environment (Latini, 2005). Indeed, human is 
being exposed to DEHP for life time from in utero. The average 
daily exposure of human to DEHP is estimated to be 0.003-
0.03 mg/kg/day (7.7-77 μmole/kg/day) (Agency for Toxic Sub-
stances and Disease Registry, 2002) and exposure of children 
is considered more serious because DEHP penetrates into 
placenta, excreted into breast milk and is heavily used in the 
packaged food materials and toys (Main et al., 2006; Schet-
tler, 2006). Reflecting this, Cutanda et al. (2015) demonstrated 
that urine level of phthalates is higher in children than moth-
ers. In the worst case scenario examining the infants admitted 
to Neonatal Intensive Care Unit, measurement of urine level 
of phthalate metabolites suggested the daily exposure level to 
reach up to 233-352 μg/kg bw/day (Weuve et al., 2006). 
Biological effects of phthalates are largely considered from 
their endocrine disruptor activity (Ohtani et al., 2000; Feige et 
al., 2007). Reproductive organs (testis and uterus) (Mylchre-
est et al., 1999), adipose tissues (Campioli et al., 2011) and 
thyroids (Liu et al., 2015; Dong et al., 2017) have been sug-
gested as the major target organs of phthalate-mediated toxic-
ity. Of these, recent interests are being directed to the effects 
of phthalates on the thyroid tissue and thyroid hormone regu-
lation. Indeed, correlation between serum thyroid hormone 
levels and DEHP metabolites has been revealed in US, Dan-
ish and Taiwanese population (Boas et al., 2006; Meeker et 
al., 2007; Meeker and Ferguson, 2011; Wu et al., 2013). This 
issue has drawn further attention in relation with increased 
incidences of thyroid cancer worldwide (Davies and Welch, 
2006). To elucidate the effects of phthalates on the thyroid, in 
vivo rodent studies have been conducted which revealed the 
alteration of thyroid following the exposure to DEHP (Liu et al., 
2015; Dong et al., 2017), where significant effects on thyroid 
hormone and metabolism were noted. However, these studies 
employed extremely high doses of DEHP ranging 150 mg/kg 
to 600 mg/kg, which are rather unrealistic in terms of human 
exposure levels of 0.003-0.03 mg/kg/day (7.7-77 μmole/kg/
day). 
Here we investigated whether the subchronic exposure 
to low dose DEHP in juvenile animals from their weaning to 
maturity may affect the thyroid with a special attention to the 
proliferative changes in the thyroid. To identify the possible 
effects on the thyroid, expression of genes related with thy-
roid hormone homeostasis was examined with RNAseq tech-
nique in the thyroid tissue and blood of the exposed animals. 
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Fig. 1. Body weight and food consumption of juvenile rats exposed to DEHP for 90 days. Body weights of male (A) and female (C) rats 
orally exposed to DEHP at 0, 0.3, 3, 30 and 150 mg/kg/day. Food consumptions of male (B) and female (D) rats. Data are mean ± SD of 
9-10 animals. *p<0.05 (One-way ANOVA) followed by Bonferroni post hoc to examine the difference from 0 mg/kg/day.
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We employed 0.3, 3, 30 and 150 mg/kg to cover the highest 
human exposure level reported and the lowest level investi-
gated in vivo previously. We also measured urinary excretion 
of mono-2-ethylhexyl-phthalate (MEHP), a major metabolite of 
DEHP to estimate the systemic exposure to DEHP (Koo and 
Lee, 2007) in an effort to seek the relevance of our findings to 
human exposure scenario.
MATERIALS AND METHODS
Materials
Di-2-ethylhexylphthalate (DEHP, synonym Dioctyl phthal-
ate, ≥99.5%) was purchased from Sigma-Aldrich (St. Louis, 
CA, USA). Dose formulations were prepared on the day of 
dosing with corn oil for oral gavage administration as appropri-
ate. LC-MS grade water (Tedia, NJ, USA), acetonitrile (Burdick 
& Jackson, MI, USA), and ammonium acetate (Sigma-Aldrich) 
were used in the mobile phase of LC system.
Animals and husbandry
F0 generation male and female Sprague-Dawley (Crl:CD) 
rats were obtained from Orient Bio Inc (Gyeonggi, Korea). For 
obtaining pregnant animals, two females were placed in the 
cage with one male overnight. F1 generation male and female 
pups were selected on postnatal day (PND) 4. All procedures 
were in compliance with Animal Welfare Act and Guide for the 
Care and Use of Laboratory Animals (by ILAR publication) and 
assessed by the Institutional Animal Care and Use Commit-
tee (IACUC) of KIT (The approval number is 1704-0150). The 
animal room was maintained in a controlled environment (tem-
perature: 23 ± 3°C, humidity: 30-70%, light cycle: 12 h light/12 
h dark cycle, light intensity: 150-300 Lux, air changes: 10 to 20 
times/h). A standard rodent pellet diet (Lab Diet® #5053 PMI 
Nutrition International, Brentwood, MO, USA; irradiated by 
gamma-ray) and filtered, ultraviolet light-irradiated municipal 
tap water were provided to the animals ad libitum. 
Animal experiments
PND 4 rats were considered to be equivalent to preterm hu-
man babies (Bowman et al., 2011) and the PND 7 are believed 
to be similar to humans at birth (Beck et al., 2006). On PND 4, 
each pups are cross-fostered between litters such that each 
litter is comprised of pups originating from at least 6 different 
litters, with no litter-mates of the same sex, and containing 
no pups from the original litter. Pups were assigned to toxi-
cology and toxicokinetic groups. Male and female pups were 
administered by oral gavage once daily at dose level of 0, 0.3, 
3, 30 and 150 mg/kg/day from PND 6 to 96 for 13-week. Pa-
rameters including mortality, clinical sign, body weight, food 
consumption, sexual maturation, organ weight, clinical pathol-
ogy, macro- and microscopic findings were examined. Urine 
was collected for 16 h from dosing the day 91 for the analysis 
of MEHP, a major metabolite of DEHP. Urine was stored in 
–80°C prior to analysis. Thyroid and liver were fixed in for-
malin, embedded in paraffin, and undergone section to stain 
with H&E. 
Ki-67 immunohistochemistry and quantitative analysis
For examination of thyroid cell proliferation, we processed 
immunohistochemical staining for Ki-67 as described previ-
ously (Kim et al., 2016; Jeong et al., 2017). To perform im-
munohistochemistry, samples were fixed in 4% paraformal-
dehyde and then embedded in paraffin. The sections were 
de-paraffinized and rehydrated sequentially. Antigen retrieval 
was carried out using pH6.0 Target Retrieval solution (DAKO, 
Carpinteria, CA, USA) in a pressure cooker for 15 min. After 
cooling for more than 1 h on ice, the sections were incubat-
ed in 3% H2O2 for 30 min to block endogeneous peroxidase 
activity. The sections were washed twice with PBS and incu-
bated with Protein block serum-free (DAKO) for 2 h at 25°C 
to reduce non-specific signal. Sections were incubated over-
night at 4°C with primary antibody specific for Ki-67 (abcam, 
Cambridge, UK) at a 1:200 dilution. After washing three times 
with PBS, the sections were incubated for 15 min with HRP-
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Fig. 2. Histology of livers of DEHP-treated juvenile rats, H&E. (A) 
DEHP 0 mg/kg male, (B) DEHP 0 mg/kg female, (C) DEHP 150 
mg/kg male (D) DEHP 150 mg/kg male. (Bar=20 μm). Representa-
tive slides of 9-10 animals per a group.
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Fig. 3. Histology of thyroids of DEHP-treated juvenile rats, H&E. 
(A) DEHP 0 mg/kg male, (B) DEHP 0 mg/kg female, (C) DEHP 150 
mg/kg male (D) DEHP 150 mg/kg male. (Bar=20 μm). Representa-
tive slides of 9-10 animals per a group.
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conjugated rabbit secondary antibody (DAKO) at 25°C. For 
immunohistochemistry, DAB (DAKO) was used for antibody 
development and Mayer’s Hematoxylin (DAKO) was used for 
counter staining.
For quantitative analysis, all thyroid area in each group 
samples was captured using Olympus BX43 microscope 40x 
lens (Olympups Optical Co., Shinjuku, Japan). Using the Im-
ageJ (National Institutes of Health, Bethesda, MD, USA), we 
counted total cell of each group thyroid and calculated the per-
centages of Ki-67 positive cells, respectively. 
Construction of RNA-seq libraries
Total RNA was extracted from ~30 mg of each tissue 
sample using the RNeasy Mini Kit (Qiagen, Hilden, Ger-
many) according to the manufacturer’s protocol. RNA qual-
ity was evaluated with an Agilent 2100 Bioanalyzer (Agilent 
Technologies,  Santa Clara, CA, USA). The cDNA library was 
prepared using TruSeq Stranded mRNA Library Prep Kit (Il-
lumina, San Diego, CA, USA) according to the manufacturer’s 
protocol. The mRNA was fragmented, followed by first and 
second strand cDNA synthesis. The cDNA was subject to ad-
enylation of 3’ ends and adapter ligation. cDNA sample was 
purified using AMPure XP beads (Beckman Coulter, CA, USA) 
and then used in 15 cycles of PCR amplification (Eastwin, 
Beijing, China). The cDNA library quality and size distribution 
was checked with a Bioanalyzer and DNA 1000 chip (Agilent 
Technologies). Library fragment sizes of all the samples were 
ranged between 250 and 500 bp, with a peak at ~310 bp. All 
libraries were quantified with the Qubit 3.0 Fluorometer (Ther-
mo Fisher Scientific, Waltham, MA, USA) and sequenced by 
NextSeq 500 sequencing system (Illumina).
RNA-seq data analysis
FastQC was used to check the sequence quality of the 
reads. The cutadapt was then used to clean the reads by re-
moving adapter sequences. The cleaned reads were aligned 
to the Ensembl rn5 rat transcriptome to obtain gene-level 
expression count data with subread R package (Liao et al., 
2013). For each gender and tissue, differential expression 
was tested for 150 mg/kg and 0.3 mg/kg versus vehicle con-
trol group, in which the vehicle control group was used as the 
control. The differential expression analysis was performed 
with DESeq2 R package (Love et al., 2014).
Urine analysis for mono-ethylhexyl phthalate, MEHP
Analysis for the determination of urinary excretion of MEHP 
was conducted as previously reported (Kato et al., 2005; Te-
itelbaum et al., 2008). Urine 0.5 ml of method blank, MEHP 
standards (1, 2, 5, 10, 20, 50, 100 and 200 ppb, Accustan-
dard. Inc., New Haven, CT, USA), quality control samples, (QL 
5 ppb, QM 50 ppb, QH 200 ppb) and samples were mixed 
with 2 M ammonium acetate buffer 1 ml and β-glucuronidase 
(Sigma-Aldrich) 20 μl and incubated for 15 h in 37°C incuba-
tor. After hydrolysis, the samples were mixed with 2 N HCl 100 
A
B
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Fig. 4. Cell proliferation in the thyroids of DEHP-treated juvenile rats. Photomicrograph of the immunohistochemistry for Ki-67 to evaluate 
thyroid cell proliferation, (A) DEHP 0, 0.3, 3, 30 and 150 mg/kg male, (B) DEHP DEHP 0, 0.3, 3, 30 and 150 mg/kg female. Representative 
slides and arrow heads indicating Ki-67+ cells.
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μl, 200 ppb internal standard (MEHP-13C2, Cambridge Isotope 
Laboratories. Inc. Tewksbury, MA) 50 μl and ethyl acetate 4 ml 
for extraction. After agitation in vortex for 5 min, samples were 
centrifuged at 4000 rpm for 10 min and then, supernatant was 
separated into 3 ml glass tube. After vaporization in N2 con-
centrator, the residue was re-dissolved into 60% acetonitrile 
100 μl. 10 μl aliquot was injected into LC-MS/MS instrument 
(Agilent 1200 series (LC) / Agilent 6460 QQQ (MS), Agilent, 
Santa Clara, CA, USA). 
Analytes were separated on CAPCELL PAK C18 MG II 3.0 
mm×150 mm 3 μm (Shiseido, Tokyo, Japan) with a gradient 
condition with mobile phase A (0.1% acetic acid in D.W) and B 
(0.1% acetic acid in acetonitrile) varying mobile phase A from 
90% to 0% for 20 min then back to 90% by 30 min at the col-
umn temperature of 35°C with the flow rate of 0.3 ml/min. MS 
detector condition was as follows; capillary voltage –4000 V, 
EMV 700, nebulizer 50 psi, gas temperature 350°C, gas flow 
10 ml/min. MEHP was detected as 277.2 → 134.1 while IS 
was 281.2 → 137.1. Limit of quantitation (LOQ) for MEHP is 
5 ng/ml. 
Statistics
Statistical analyses for comparisons of the various dose 
groups with the vehicle control group were conducted using 
Pristima System (Version 6.4. Xybion Medical Systems Corpo-
ration, Morris Plains, NJ, USA). Difference from control (0 mg/
kg) group was examined using Student t-test. When multiple 
comparison tests for different dose groups were conducted, 
variance of homogeneity was examined using the Bartlett’s 
Test. Homogeneous data was analyzed using the Analysis of 
Variance (ANOVA) and the significance of inter-group differ-
ences were analyzed using Dunnett’s Test or Bonferroni post 
hoc test. Heterogeneous data was analyzed using Kruskal-
Wallis Test and the significance of inter-group differences be-
tween the control and treated groups were assessed using 
Dunn’s Rank Sum Test. RNAseq data were tested with likeli-
hood ratio test in DESeq2 R package.
RESULTS
Effects of DEHP on body weight change, food 
consumption, hematology and blood chemistry in 
juvenile rats
To examine the effects of DEHP exposure during young 
ages on the thyroid, juvenile rats (at the time of weaning, post-
natal day 6) were orally administered with DEHP dissolved in 
corn oil for 90 days. There were no meaningful clinical signs 
related with the treatment. The body weight was not affected 
by the exposure to DEHP at any dose levels in both sexes 
(Fig. 1A, 1C) but reduced food consumption were noted spo-
radically in 30 mg/kg male group and all the dosed female 
groups (Fig. 1B, 1D). Especially in 0.3 mg/kg female group, a 
significant reduction of food consumption as high as 18% was 
noted from day 30 to day 65. 
Hematology as well as blood coagulation assay revealed 
that no significant differences in both male and female rats 
exposed to DEHP were noted (Supplementary Table 1). Blood 
chemistry showed that γ-glutamyl transpeptidase (GGT) de-
creased at the dose of 30 mg/kg and 150 mg/kg in female 
(0.27 ± 0.21 and 0.18 ± 0.23 versus 0.60 ± 0.34, p<0.05, stu-
dent t-test, Supplementary Table 2). Other statistically signifi-
cant changes noted in dosing groups compared with the con-
trol were not considered treatment-related, as these values 
were within the normal ranges of biological variation.
Effects of oral treatment of DEHP on the sexual 
maturation and organ weights
To examine the effects of DEHP on the sexual maturation 
of male and female juvenile rats, prepuptial separation and 
vaginal opening time were examined respectively. Exposure 
to DEHP did not affect the sexual maturation of juvenile rats of 
both sexes (data not shown). 
However, measurement of absolute (Supplementary Table 
3) and relative organ weights (Supplementary Table 4) re-
vealed that kidney and liver of male and female rats dosed 
with 150 mg/kg DEHP showed increased weights. In addition, 
mammary glands of male dosed at 30 mg/kg and left ovaries 
of female dosed at 3 and 30 mg/kg decreased in absolute or 
relative weights.
Histopathological examination of the liver and thyroid of 
the juvenile rats exposed to DEHP
Previously, DEHP administration was known to affect liver 
and thyroid at the doses above 250 mg/kg (Liu et al., 2015; 
Dong et al., 2017). While there were no treatment related his-
tological findings in liver (Fig. 2), hyperplasia and hypertrophy 
of thyroid glands were evident in the rats administered with 
DEHP 150 mg/kg for 90 days (Fig. 3). To further confirm this, 
thyroid tissues were immunohistochemically stained for Ki67 
to quantitate the proliferative changes (Fig. 4). Significant in-
creases in proliferating cells in the male rats dosed at 150 mg/
kg and female at 30 and 150 mg/kg were demonstrated (Table 
1), reflecting that DEHP exposure may induce proliferative al-
teration of thyroid tissue. 
Table 1. Counts of Ki67 positive cells in the thyroid tissue of rats orally administered with DEHP for 90 days
DEHP (mg/kg)
Male Female
Ki67 Non-Ki67 Total cell Ki67 Non-Ki67 Total cell
0 74 18268 18342 47 14437 14484
0.3 119 22798 22917 95 23933 24028
3 85 19844 19929 57 16275 16332
30 136 25830 25966 111* 18786 18897
150 285* 22620 22905 115* 19256 19371
*p<0.05 by c2 test.
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Expression of genes related with thyroid physiology 
examined with RNAseq technique in the thyroid and 
blood of the rats exposed to 0.3 mg/kg and 150 mg/kg 
DEHP
Previous studies have shown that high doses of DEHP can 
upregulate the genes like thyroid peroxidase, thyroid deiodin-
ase 1, thyroid stimulating hormone receptor, sodium/iodide 
symporter (NIS), and thyroglobulin but it was not examined 
whether lower doses also can alter the genes related to thyroid 
physiology. To identify the gene expression changes induced 
by DEHP regarding thyroid hormone homeostasis, expression 
of related genes in the thyroid and blood of the rats treated 
with 0.3 mg/kg were quantitated with RNAseq technique. As 
a result, in the thyroid, thyrotropin-releasing hormone (Trh) 
gene was found to be up-regulated significantly in the female 
rats dosed with 0.3 mg/kg DEHP (Fig. 5A). Interestingly, sig-
nificantly increased mRNA expression of parathyroid hormone 
(Pth) in the female 0.3 mg/kg (Fig. 5B), and thyroglobulin (Tg) 
(Fig. 6A) and thyroid hormone responsive (Thrsp) (Fig. 6B) 
in the male 0.3 mg/kg group were also found in the blood re-
flecting that DEHP may affect the thyroid hormone regulation, 
which is in line with the histopathological examination. Inter-
estingly, these changes were substantially attenuated at 150 
mg/kg, reflecting that distinct effects of low dose DEHP may 
exist.
Urine analysis for mono-ethylhexyl phthalate, MEHP
To estimate the systemic exposure of DEHP in this study, 
urine was collected for 16 h on the final dosing day and mea-
sured for the concentration of MEHP, a major bio-metabolite 
of DEHP using LC/MSMS. To assess the total MEHP (free and 
conjugated forms), samples were treated with β-glucuronidase 
before analysis. As shown in Table 2, urinary excretion of 
MEHP increased dose-dependently by DEHP (from 4.10 to 
12.26 ppb in male, from 6.65 to 324 ppb in female at 0.3 to 30 
mg/kg) where the female exhibited higher systemic exposure 
over male.
DISCUSSION
Here we demonstrated that the exposure to DEHP during 
young ages may induce proliferative changes in the thyroid 
and alter gene expression related to thyroid hormone regula-
tion. Ratio of proliferative cells was significantly increased in 
female rats dosed at 30 and 150 mg/kg and in male at 150 mg/
kg. Although evident proliferative changes were not observed 
in 0.3 mg/kg, significant changes in the mRNA levels of the 
genes such as Trh, Pth, Tg and Thrsp were induced, reflect-
ing that low dose phthalates may also influence thyroid hor-
mone regulation. Urinary excretion of MEHP increased dose-
dependently but a considerable gender difference was noted 
where the female rats exhibited higher systemic exposure 
amounting to 1.6 to 146 fold over male as the dose increases. 
Importantly, highest urinary metabolites of phthalates in hu-
man were reported at the ranges of 47.1 ppb to 331 ppb which 
was coincided with the levels shown in our study (from 4.10 
to 12.26 ppb in male, from 6.65 to 324 ppb in female at 0.3 to 
30 mg/kg) suggesting the potential adverse effects of the low 
dose phthalates on the thyroid in human.
Along with other endocrine disruptors like bisphenol A 
(Chung et al., 2017; Jeong et al., 2017; Kim et al., 2018), car-
cinogenic effects of phthalates have drawn attention due to 
their ubiquitous presence in community and environment. The 
association of phthalate exposure with the risk of cancer in 
human has been illuminated by the seminal study of López-
Carrillo L et al., who showed that exposure to DEHP may be 
associated with increased risk of breast cancer (Lopez-Carrillo 
et al., 2010). Potential risk of pancreatic cancer has been also 
suggested (Selenskas et al., 1995; Ventrice et al., 2013). The 
carcinogenic effects of phthalates have been explained by the 
activation of peroxisome proliferator-activated receptors and 
aryl hydrocarbon receptor mediated transcription pathways 
(Hsieh et al., 2012). Mechanism behind the proliferative ef-
fects of DEHP on the thyroid can also be speculated into its 
endocrine disrupting (antagonistic) effects of thyroid hormone 
homeostasis and hypothalamus-pituitary-thyroid axis (Zhai 
et al., 2014). Liu et al. (2015) showed that in vivo exposure 
to high dose of DEHP for 30 days in rats reduced circulat-
ing T3, T4 thyroid hormone and thyrotropin releasing hormone 
(TRH) which reached statistical significance at 500-750 mg/
kg. In line with this, Liu et al. (2015) found that suppression of 
biosynthesis, and transport of thyroid hormone was noted as 
determined by reduced sodium iodide symporter and thyroid 
peroxidase levels, which they attributed to the elevation of he-
patic enzymes involved in the thyroid hormone elimination and 
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Fig. 5. Gene expression changes in the thyroid and blood of fe-
male rats exposed to DEHP at 0.3 mg/kg and 150 mg/kg. Of the 
genes examined by RNAseq, statistically, significantly changed 
genes with more than 2 fold in the thyroid and blood were shown, 
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posed to DEHP at 0.3 mg/kg and 150 mg/kg. Of the genes ex-
amined by RNAseq, statistically, significantly changed genes with 
more than 2 fold in the thyroid and blood were shown, (A) Tg 
mRNA levels in the blood of male, (B) Thrsp mRNA levels in the 
blood of male. (N=3), **significant at p<0.01 by likelihood ratio test 
in DESeq2 R package. 
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resultant acceleration of thyroid hormone metabolism. Dong 
et al. (2017) also confirmed the decreased thyroid hormone 
levels in the rats exposed to DEHP at 150, 300, and 600 mg/
kg for 3 and 6 months. 
While evidence on the disruption of thyroid hormone ho-
meostasis by DEHP is strong, previous studies have not ad-
dressed the possible implication on the proliferative changes 
on thyroid induced by DEHP. Dong et al. demonstrated that 
exposure to the high dose of DEHP induced pronounced fat 
degeneration, fat drops, empty lipocytes, and apoptosis cell 
in thyroid tissues (Dong et al., 2017) but it remains unclear 
whether DEHP can induce proliferation of thyroid cells, which 
is a vital line of evidence linking DEHP exposure and thyroid 
cancer. Liu et al. (2015) demonstrated that extremely high 
doses of DEHP (500 and 750 mg/kg) induced hyperplasia 
but it is hard to find a relevance of this dose level to realis-
tic human exposure. To fill this gap, we examined lower dose 
ranges that cover the reported human exposure level, and the 
lowest dose explored for the effects on thyroid in other studies. 
Human urine levels of phthalate metabolites were reported 
to be from 47.1 ng/ml (mono-n-butyl phthalate (MnBP), me-
dian) in school children (Wang et al., 2015) to 331 ng/ml (total 
phthalate metabolites, median) in China (Guo et al., 2011), 
that were in proximate ranges with the urinary excretion lev-
els we measured. Indeed, quantitation of MEHP in the pooled 
urine samples revealed that female 30 mg/kg group, which 
showed significantly increased Ki67 expressing proliferating 
cells in the thyroid, showed 106.28-604.95 ng/ml. Moreover, 
gene expression changes in the thyroid and blood could be 
observed at 0.3 mg/kg doses which showed urinary MEHP 
levels of 4.00 to 4.23 ng/ml in males and 5.18 to 8.45 ng/ml in 
females, which further supports the relevance of our results to 
the real human exposure. 
In conclusion, we demonstrated that exposure to low-dose 
DEHP in juvenile rats from young ages to maturity, may in-
duce proliferative changes in thyroid tissues without changes 
in liver histology. Even without clear histological changes, sig-
nificant changes in the mRNA levels of the genes related with 
thyroid hormone regulation such as Trh, Pth, Tg and Thrsp 
were induced at 0.3 mg/kg DEHP. The urinary excretion of 
MEHP was comparable to the reported human urinary phthal-
ate metabolite levels, supporting the relevance of our findings 
to real human exposure. Further studies on the links of low 
dose phthalate exposure with human thyroid cancer are war-
ranted to fully elucidate the potential risk of thyroid toxicity of 
phthalates.
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